Theratechnologies Inc (TH):企業の財務・戦略的SWOT分析

【英語タイトル】Theratechnologies Inc (TH) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C4823)・商品コード:DATA904C4823
・発行会社(調査会社):GlobalData
・発行日:2018年8月
・ページ数:56
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Theratechnologies Inc (TH) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Theratechnologies Inc (Theratechnologies) is a pharmaceutical company that focuses on the discovery and development of drugs for metabolic disorders. The company develops therapeutic peptide products, with an emphasis on growth releasing factor (GRF) peptides. Its lead products include Egrifta (tesamorelin for injection) is indicated to reduce excess abdominal fat in HIV-infected patients with lipodystrophy; and Trogarzo, indicated for the treatment of human immunodeficiency virus type 1 infection in the US. The proprietary technologies of Theratechnologies include long acting peptides, a peptide stabilization technology to increase target protein’s resistance to enzymatic degradation. Theratechnologies is headquartered in Montreal, Quebec, Canada.

Theratechnologies Inc Key Recent Developments

Aug 28,2018: Theratechnologies Files Marketing Authorization Application for Trogarzo in Europe
Jul 05,2018: Theratechnologies Announces Financial Results for the Second Quarter of 2018
Apr 30,2018: Theratechnologies’ CEO and CFO to Attend Bloom Burton Healthcare Investor Conference in Toronto
Apr 05,2018: Theratechnologies Announces Financial Results for First Quarter of 2018
Feb 07,2018: Theratechnologies Announces Financial Results for Fiscal Year 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Theratechnologies Inc – Key Facts 5
Theratechnologies Inc – Key Employees 6
Theratechnologies Inc – Key Employee Biographies 7
Theratechnologies Inc – Major Products and Services 8
Theratechnologies Inc – History 9
Theratechnologies Inc – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Theratechnologies Inc – Business Description 14
Theratechnologies Inc – Corporate Strategy 15
Theratechnologies Inc – SWOT Analysis 16
SWOT Analysis – Overview 16
Theratechnologies Inc – Strengths 16
Theratechnologies Inc – Weaknesses 17
Theratechnologies Inc – Opportunities 18
Theratechnologies Inc – Threats 19
Theratechnologies Inc – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Theratechnologies Inc, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Jul 05, 2018: Theratechnologies Announces Financial Results for the Second Quarter of 2018 31
Apr 05, 2018: Theratechnologies Announces Financial Results for First Quarter of 2018 34
Feb 07, 2018: Theratechnologies Announces Financial Results for Fiscal Year 2017 36
Oct 05, 2017: Theratechnologies Announces Financial Results for Third Quarter of 2017 39
Jul 12, 2017: Theratechnologies Announces Financial Results for Second Quarter of 2017 42
May 16, 2017: Shareholders elect new Board member during Theratechnologies’ annual meeting 45
Apr 06, 2017: Theratechnologies Announces Financial Results for First Quarter of 2017 46
Feb 08, 2017: Theratechnologies Announces Financial Results for Fiscal Year 2016 49
Section 6 – Appendix 52
Methodology 52
Ratio Definitions 52
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
Theratechnologies Inc, Key Facts 5
Theratechnologies Inc, Key Employees 6
Theratechnologies Inc, Key Employee Biographies 7
Theratechnologies Inc, Major Products and Services 8
Theratechnologies Inc, History 9
Theratechnologies Inc, Subsidiaries 12
Theratechnologies Inc, Key Competitors 20
Theratechnologies Inc, Ratios based on current share price 21
Theratechnologies Inc, Annual Ratios 22
Theratechnologies Inc, Annual Ratios (Cont...1) 23
Theratechnologies Inc, Annual Ratios (Cont...2) 24
Theratechnologies Inc, Interim Ratios 26
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Theratechnologies Inc, Recent Deals Summary 30
Currency Codes 52
Capital Market Ratios 52
Equity Ratios 53
Profitability Ratios 53
Cost Ratios 54
Liquidity Ratios 54
Leverage Ratios 55
Efficiency Ratios 55

List of Figures
Theratechnologies Inc, Performance Chart (2013 - 2017) 25
Theratechnologies Inc, Ratio Charts 27
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

★調査レポート[Theratechnologies Inc (TH):企業の財務・戦略的SWOT分析] (コード:DATA904C4823)販売に関する免責事項を必ずご確認ください。
★調査レポート[Theratechnologies Inc (TH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆